Kevin Punie

Wilrijk, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 134 publications

Digital health technology in oncology: results from a survey by the ESMO Young Oncologists Committee and medical student alumni.

Digital health technology in oncology: results from a survey by the ESMO Young Oncologists Committee and medical student alumni.

Journal: ESMO real world data and digital oncology
Published: April 09, 2026

Preoperative Radiation Therapy and Immediate Breast Reconstruction, a phase 3 randomized controlled trial in the Belgian population (PRADAIIBE): a study protocol.

Preoperative Radiation Therapy and Immediate Breast Reconstruction, a phase 3 randomized controlled trial in the Belgian population (PRADAIIBE): a study protocol.

Journal: BMC cancer
Published: March 02, 2026

Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer.

Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer.

Journal: The New England journal of medicine
Published: October 22, 2025

ESMO Adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.

ESMO Adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 10, 2025

ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.

ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 10, 2025

Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE.

Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE.

Journal: BMJ open
Published: August 27, 2025

Inherited cancer syndromes in adult oncology: a referral guide based on malignant tumor and polyp features.

Inherited cancer syndromes in adult oncology: a referral guide based on malignant tumor and polyp features.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: August 21, 2025

Q-TWiST Analysis to Assess Benefit-Risk of Sacituzumab Govitecan in Previously Treated Patients With Metastatic Triple-Negative Breast Cancer.

Q-TWiST Analysis to Assess Benefit-Risk of Sacituzumab Govitecan in Previously Treated Patients With Metastatic Triple-Negative Breast Cancer.

Journal: JCO oncology practice
Published: June 25, 2025

The role of body mass index at diagnosis in patients with inflammatory breast cancer.

The role of body mass index at diagnosis in patients with inflammatory breast cancer.

Journal: Breast (Edinburgh, Scotland)
Published: June 18, 2025

Hereditary breast cancer beyond BRCA: clinicopathological characteristics and long-term outcomes.

Hereditary breast cancer beyond BRCA: clinicopathological characteristics and long-term outcomes.

Journal: Familial cancer
Published: January 13, 2025

Expression of antibody-drug conjugate targets in post-mortem samples of breast cancer metastases and normal tissue.

Expression of antibody-drug conjugate targets in post-mortem samples of breast cancer metastases and normal tissue.

Journal: Nature communications
Published: January 02, 2025

Oncology professionals' perceptions and recommendations to improve well-being and health at work in times of crisis: qualitative thematic analysis from the ESMO Resilience Task Force survey series.

Oncology professionals' perceptions and recommendations to improve well-being and health at work in times of crisis: qualitative thematic analysis from the ESMO Resilience Task Force survey series.

Journal: ESMO open
Published: November 19, 2024
Showing 1-12 of 134

Last Updated: 09/26/2026